Extrait

To demonstrate comparable efficacy as measured by the composite efficacy failure of tBPAR, graft loss or death with EVR in combination with rTAC compared to standard exposure TAC, at 12 months post-transplantation, in living donor liver transplant recipients.

Critère d'inclusion

• Adults with end stage liver disease patients requiring a liver transplant

Liens

• euctr
• ictrp
• ictrp
• euctr